EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Extended field radiation therapy vs. delayed hormonal therapy in node positive prostatic adeno carcinoma



Extended field radiation therapy vs. delayed hormonal therapy in node positive prostatic adeno carcinoma



Journal of Urology 127(5): 935-937



The disease control and survival advantage of either extended field megavoltage irradiation or delayed androgen ablation in a randomized [human] clinical trial were determined. Comparison of the 2 treatments, using either time to 1st evidence of treatment failure or survival, demonstrates an advantage to extended field radiation.

(PDF 0-2 workdays service: $29.90)

Accession: 005432587

Download citation: RISBibTeXText



Related references

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma. Journal of Urology 127(5): 935-937, 1982

Extended-field radiation therapy for prostatic carcinoma with para-aortic lymph node metastasis. American Journal of Clinical Oncology 9(4): 302-306, 1986

The use of combined radiation therapy and hormonal therapy in the management of lymph node-positive prostate cancer. International Journal of Radiation Oncology Biology Physics 39(3): 673-680, 1997

External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy. Radiation Medicine 13(6): 297-300, 1995

Chemo therapy and radiation of nb rat prostatic adeno carcinoma nb pr a 1 1. Journal of Surgical Research 28(6): 492-496, 1980

Delayed and late regression of bone metastases during endocrine therapy of prostatic adeno carcinoma. Proceedings Of The American Association For Cancer Research & American Society Of Clinical Oncology: 2, 1981

Hormonal therapy of prostatic carcinoma: is there a rationale for delayed treatment?. Urology 27(3): 199-204, 1986

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45(4): 616-623, 1995

Combined hormonal and radiation therapy for prostatic carcinoma. Strahlentherapie und Onkologie 167(9): 523-529, 1991

Combined hormonal and radiation therapy for lymph node-positive prostate cancer. Urology. 46(2): 213-219, 1995

The combined radiation and hormonal therapy of prostatic carcinoma: a conceptual analysis. Strahlentherapie und Onkologie 167(9): 523-529, 1991

Treatment of prostatic carcinoma in clinical stage C. Comparison between radiotherapy plus hormonal therapy after progression and immediate hormonal therapy. Minerva Urologica E Nefrologica 46(2): 123-128, 1994

Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. International Journal of Radiation Oncology, Biology, Physics 90(5): 1091-1098, 2015

The value of extended field radiation therapy in carcinoma of the prostate. International Journal of Radiation Oncology, Biology, Physics 7(10): 1333-1340, 1981